{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:58:26Z","timestamp":1785484706879,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":110,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100590","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:10:38Z","timestamp":1776874238000},"page":"100590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the effectiveness of reduced-intensity conditioning regimens in acute myeloid leukemia patients after hematopoietic stem cell transplantation in Vietnam"],"prefix":"10.1016","volume":"25","author":[{"given":"Man Van","family":"Huynh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4052-7777","authenticated-orcid":false,"given":"Huu Than","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2146-7078","authenticated-orcid":false,"given":"Thu Hanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong Thanh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan Tuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Duy","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Dung","family":"Phu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2026.100590_bib0001","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100590_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2011.69","article-title":"Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS","volume":"47","author":"Luger","year":"2012","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2014.199","article-title":"Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML","volume":"50","author":"Sebert","year":"2015","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0004","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1704889","article-title":"Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation","volume":"35","author":"Larosa","year":"2005","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12003","article-title":"Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens","volume":"15","author":"Kim","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.lrr.2026.100590_bib0006","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/sj.leu.2403967","volume":"19","author":"Aoudjhane","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2026.100590_bib0007","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100590_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2018.01.031","article-title":"A modified post-transplant cyclophosphamide regimen, for unmanipulated haploidentical marrow transplantation, in acute myeloid leukemia: a multicenter study","volume":"24","author":"Chiusolo","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2018.05.024","article-title":"Propensity score analysis of conditioning intensity in peripheral blood haploidentical hematopoietic cell transplantation","volume":"24","author":"Huselton","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0010","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1182\/bloodadvances.2019001266","article-title":"Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report","volume":"4","author":"Zhou","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.lrr.2026.100590_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2018.09.012","article-title":"The dilemma of conditioning intensity: when does myeloablative conditioning improve outcomes for allogeneic hematopoietic cell transplantation","volume":"25","author":"Solh","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0012","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2018021980","article-title":"Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity","volume":"2","author":"Eapen","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.lrr.2026.100590_bib0013","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2006.09.7865","article-title":"Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation","volume":"25","author":"Sorror","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2026.100590_bib0014","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100590_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.09.029","article-title":"A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia","volume":"21","author":"Yahng","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.05.025","article-title":"Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival","volume":"20","author":"Koreth","year":"2014","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.08.013","article-title":"Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10\/10 human leukocyte antigen-matched unrelated and related donors","volume":"20","author":"Di Stasi","year":"2014","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-020-0856-y","article-title":"Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan","volume":"55","author":"Yamashita","year":"2020","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.lrr.2026.100590_bib0019","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2026.100590_bib0020","article-title":"Haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide: a single-center initial experience in Vietnam","volume":"4","author":"Huynh","year":"2021","journal-title":"Blood Cell Ther."},{"key":"10.1016\/j.lrr.2026.100590_bib0021","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.62.7273","volume":"33","author":"Devine","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2026.100590_bib0022","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2020.268839","article-title":"Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend \"when and for whom\" in 2021?","volume":"106","author":"Gagelmann","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.lrr.2026.100590_bib0023","doi-asserted-by":"crossref","DOI":"10.1007\/s12288-020-01386-6","article-title":"Myeloablative versus reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplant for acute myeloid leukemia and myelodysplastic syndrome: a retrospective analysis","volume":"37","author":"Sharma","year":"2021","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.lrr.2026.100590_bib0024","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.25.4821","article-title":"Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome","volume":"28","author":"McClune","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2026.100590_bib0025","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-08-303263","article-title":"Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients","volume":"117","author":"Smith","year":"2011","journal-title":"Blood"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:11:52Z","timestamp":1785481912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["S2213048926000300"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100590","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the effectiveness of reduced-intensity conditioning regimens in acute myeloid leukemia patients after hematopoietic stem cell transplantation in Vietnam","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100590"}}